Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDT-ASCT vs R-DeVIC in Primary CNS Lymphoma
NCT02531841Phase 3Unknown
- Sponsor
- University Hospital Freiburg
- Start
- Jul 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carmustine, thiotepa in primary central nervous system lymphoma (PCNSL), sponsored by University Hospital Freiburg. Status: unknown.
02
Drugs
carmustinethiotepa
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT02531841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531841.